- Coinfections with Respiratory Syncytial Virus (RSV) in a Cohort of Adults with Pre-Existing Comorbidities in Wisconsin from 2015-16 through 2019-20. ID Week 2024, Los Angeles, CA, October 16-October 19, 2024.
- Seasonal incidence of symptomatic RSV during the COVID-19 pandemic in a rural community cohort: Wisconsin, USA 2021-2023. Options XII for the Control of Influenza, Brisbane, Australia, September 29-October 2, 2024.
- Effectiveness of cell culture-based inactivated influenza vaccine against medically-attended, laboratory-confirmed influenza in Wisconsin, US, 2023-2024. Options XII for the Control of Influenza, Brisbane, Australia, September 29-October 2, 2024.
- Cumulative Incidence of RSV from 2015-16 Through 2019-20 in a High-Risk Adult Population in a Rural US Community. Options XII for the Control of Influenza, Brisbane, Australia, September 29-October 2, 2024.
- Optimizing the Modified Bernie Norwood Criteria with History of Anticoagulation: A National Analysis of Very Early (<24 hrs.) Versus Later VTE Prophylaxis in the Trauma Population: Wisconsin and South Carolina, USA 2017-2021. The AAST 2024 Annual Meeting, Las Vegas, NV September 11-September 14, 2024.
- Optimal Strategies to Estimate the Relative Effectiveness of Influenza Vaccines (SERVE): Wisconsin, USA 2021-2022. Greater Plains Collaborative Spring Learning Engagement Conference, Kansas City, MO, August 26-August 27, 2024.
- No association of incident epilepsy with up-to-date vaccination status or vaccine aluminum exposure in children less than 48 months of age: Wisconsin, USA 2018 Cycle. VSD Conference, Minneapolis, MN, May 20-May 23, 2024.
- Rapid Cycle Analysis of Respiratory Syncytial Virus Vaccines in Older Adults in VSD: Wisconsin, USA, 2023-2024. VSD Conference, Minneapolis, MN, May 20-May 23, 2024.
